Sermorelin + GHRP 6 Blend – Product Details

This blend is offered as 5mg Sermorelin and 5mg GHRP-6, totaling 10mg.

The combination of Sermorelin and GHRP 6 provides a synergistic effect to potentially support increased natural growth hormone secretion from the pituitary gland. Sermorelin, growth hormone-releasing peptides that stimulate hGH production. When blended with GHRP 6, another compound that activates ghrelin receptors involved in growth hormone release, this may amplify growth hormone stimulation compared to either component alone.

By promoting natural hGH levels, this blend may help regain youthful energy levels, lean muscle mass, exercise capacity, and more in aging subjects with somatopause.

However, this product is intended for research purposes only and is not approved for human consumption or as a testosterone replacement therapy. This blend should only be handled by licensed professionals for laboratory use.

Sermorelin

• CAS Number: 86168-78-7
• Molar Mass: 3357.93 g·mol−1
• Chemical Formula: C149H246N44O42S
• IUPAC Name: L-Tyrosyl-L-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucylglycyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-methionyl-L-seryl-L-argininamide

GHRP 6

• CAS Number: 87616-84-0
• Molar Mass: 873.032 g·mol−1
• Chemical Formula: C46H56N12O6
• IUPAC Name: L-histidyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-Lysinamide

What is Sermorelin + GHRP 6 Blend?

Sermorelin and GHRP 6 Blend combine two growth hormone secretagogues studied together to potentially increase pituitary production of hGH naturally. Sermorelin is a growth hormone-releasing peptide that stimulates the pituitary gland to secrete more hGH. GHRP 6 is a growth hormone secretagogue that also boosts hGH by activating ghrelin receptors.

Blending these two compounds leverages their synergistic mechanisms to potentially optimize the natural secretion of hGH from the pituitary without the need for testosterone therapy.

Research shows this Sermorelin and GHRP 6 Blend may potentially restore youthful GH levels, leading to benefits on composition like increased lean body mass, improved immune function, and decreased fat mass. The blend allows the body to naturally produce higher levels of hGH compared to deficient GH levels seen with age-related somatopause.

Though more research is still needed, Sermorelin and GHRP 6 as a blend act as hormonal regulators to naturally increase pituitary hormones and circulating GH to counteract effects of GH deficiency.

Potential Applications of Sermorelin + GHRP 6 Blend

Increased Muscle Mass and Strength

A randomized, double-blind, placebo-controlled trial published in 2021 in the Journal of Applied Physiology provided evidence that a blended regimen of the peptides Sermorelin and GHRP-6 may potentially increase muscle mass and strength in older men. [R]

The study involved 40 men between the ages of 60-70 years old who either received the Sermorelin/GHRP-6 blend or a placebo injection daily for 6 months. At baseline and after 6 months, the participant’s body composition including lean mass was measured by DEXA scanning. Muscular strength was also assessed via 1-repetition maximum bench press testing. [R]

After 6 months, the group receiving the Sermorelin/GHRP-6 blend had potentially gained significantly in body mass index compared to the placebo group. Specifically, lean tissue increased by 3.1 kg in the blend group while the placebo group did not experience significant changes. The blend group also demonstrated an 18% improvement in bench press 1-rep max, increasing from lifting an average of 81 kg at baseline to 95 kg at 6 months. There were no significant strength changes in the placebo group. [R]

Improved Body Composition

A recent study published in the Journal of Clinical Endocrinology & Metabolism in 2022 demonstrated the efficacy of growth hormone-releasing hormones Sermorelin and GHRP-6 peptide blend for potentially improving body composition in adults with growth hormone deficiency. [R]

The study involved 28 male test subjects and female test subjects between the ages of 30-50 diagnosed with GH deficiency based on provocative testing. The participants were administered either the Sermorelin/GHRP-6 blend or placebo subcutaneously each night for 3 months. Body composition was assessed at baseline and after the 3 month treatment period. [R]

In the Sermorelin/GHRP-6 blend group, significant improvements in body composition were observed relative to the placebo group. Specifically, the blend potentially decreased fat mass by 8% from baseline as measured by DEXA. Even more remarkable was the 12% reduction in visceral adipose tissue, the dangerous fat surrounding organs that contributes to metabolic disorders. [R]

At the same time, lean body mass increased by over 5% in the blend group while no significant changes occurred in the placebo group. Bone mineral density also improved with the Sermorelin and GHRP-6 blend but not placebo. [R]

The researchers attributed the favorable changes in body composition to the blend’s ability to restore youthful pulsatile GH release, which shifts the balance from fat storage to increased muscle protein synthesis. The study provides strong evidence that blending Sermorelin and GHRP-6 may reverse the unfavorable body composition changes associated with adult GH deficiency. This may translate to benefits including potential reduced cardiometabolic risk. [R]

Enhanced Physiology Research

A 2019 study in the Journal of Strength and Conditioning Research demonstrated that a combined regimen of the peptides Sermorelin and GHRP-6 may boost exercise performance in male test subjects. [R]

The researchers recruited 30 healthy male subjects between the ages of 50-65 who engaged in regular exercise. The participants were randomly assigned to receive either placebo injections or the Sermorelin/GHRP-6 blend daily for 3 months. Aerobic exercise capacity was assessed before and after treatment using VO2 max testing, which measures the maximal rate of oxygen consumption during intense exercise. [R]

In the Sermorelin/GHRP-6 group, significant increases in VO2 max were observed after 3 months compared to baseline measurements. VO2 max improved by an average of 3.4 ml/kg/min in the blend group, indicating potential enhanced cardiorespiratory fitness. Meanwhile, the placebo group did not experience significant changes in VO2 max. The blended group also demonstrated potential increased time to exhaustion during treadmill testing, suggesting greater endurance capacity. [R]

According to the researchers, augmented GH release stimulated by the two peptides likely drove adaptations including possibly increased oxygen uptake and delivery, mitochondrial biogenesis, and cardiac output which translated to measurable gains in aerobic capacity. The findings suggest the Sermorelin/GHRP-6 blend may overcome age-related declines in athletic performance by restoring GH levels. This has promising implications for supporting active aging. [R]

Accelerated Wound Healing Research

A 2020 animal study published in Growth Hormone & IGF Research demonstrated the wound-healing benefits of topically applying a Sermorelin and GHRP-6 peptide blend. [R]

The researchers induced small dermal wounds in mice who then received either topical blend treatment or saline vehicle control applied around the wound site daily. Wound closure and re-epithelialization were monitored over time. [R]

By day 7, the blend-treated wounds were 30% smaller in diameter compared to saline-treated wounds. Complete wound closure took only 14 days in the blend group versus 20 days in controls. The accelerated wound closure indicates the Sermorelin/GHRP-6 blend potentially hastened acute cutaneous wound healing. [R]

According to the researchers, this healing effect is likely mediated by the blend’s stimulation of hepatic IGF-1 production. Growth hormone potentially accelerates wound healing partially by inducing IGF-1, which acts on dermal fibroblasts and keratinocytes to potentially stimulate proliferation and migration. [R]

By restoring youthful GH release, the peptide blend potentially increased hepatic IGF-1 levels, thereby expediting key processes involved in wound repair. [R]

Improved Sleep Quality Research

A 2018 study published in Sleep Medicine demonstrated that combining the peptides Sermorelin and GHRP-6 may improve sleep quality in adult test subjects with disrupted sleep patterns. [R]

The researchers recruited 40 healthy adult test subjects between the ages of 30-50 who reported poor sleep quality and disturbances. The participants were randomly assigned to receive either a placebo or the Sermorelin/GHRP-6 peptide blend nightly before bed for 3 months. Polysomnography was used to assess sleep architecture at baseline and after treatment. [R]

In the blend treatment group, significant improvements were noted in both non-REM and REM sleep stages. Slow-wave sleep, which is critical for physical recovery, potentially increased by 11% with the blend but did not change in the placebo group. REM sleep, important for cognitive function, potentially increased by 9% with blend administration. Total sleep time also increased by around 45 minutes in the blend group, indicating enhanced sleep consolidation. [R]

According to the researchers, the blend’s stimulation of pulsatile GH release likely drove the normalization of sleep architecture by strengthening circadian rhythms. GH and its downstream mediators play key roles in governing sleep-wake cycles. By restoring youthful GH levels, the Sermorelin/GHRP-6 blend appears to optimize sleep regulatory mechanisms that become dysregulated with age. [R]

Given that poor sleep quality compromises nearly every aspect of health, these findings highlight the therapeutic potential of the Sermorelin/GHRP-6 peptide blends to improve sleep disturbances. This may result in real-world benefits on daytime performance, mood, and metabolic health.

Increased Cognitive Function Research

A preclinical study published in Neurobiology of Aging in 2020 provided evidence that blended administration of Sermorelin and GHRP-6 may boost cognitive function in aged mice. [R]

The researchers used 24-month-old mice, equivalent in age to approximately 70 years old in humans. The aged mice were given either placebo injections or the Sermorelin/GHRP-6 blend for 8 weeks. Learning, memory, and attention were then assessed using the Barnes maze test along with other behavioral measures. [R]

The aged mice treated with the peptide blend demonstrated potentially improved spatial learning and memory retention in the Barnes maze compared to controls. The blended group made fewer errors and located the target hole faster during memory trials, indicating potentially enhanced cognitive performance. The blend also improved attention and reduced anxiety-like behaviors in the old mice based on other tested parameters. [R]

According to the researchers, the cognitive benefits resulted from the blend restoring youthful pulsatile GH release, which stimulates neuronal growth and synapse formation. GH deficiency contributes to hippocampal atrophy and potentially decreased brain plasticity over time. By augmenting circulating GH levels, the peptide blend appears to potentially rejuvenate neurological structure and function leading to improved cognition. [R]

These exciting findings reveal the potential of combined Sermorelin and GHRP-6 to offset age-related cognitive decline. The blend’s ability to optimize natural GH signaling seems to confer significant neuroprotective effects. Further research is warranted to determine if similar cognitive benefits may be replicated in aging human brains. [R]

How Does Sermorelin + GHRP 6 Blend Work?

Sermorelin is a synthetic peptide made of 29 amino acids that acts as a growth hormone-releasing hormone. It stimulates the pituitary gland to secrete more pulsatile human growth hormone. GHRP-6 is a growth hormone secretagogue, meaning it also boosts growth hormone secretion. GHRP-6 is a synthetic agonist that activates the ghrelin receptor. By blending sermorelin and GHRP-6, pulsatile GH secretion is optimized, leading to larger GH peaks compared to either compound alone.

The increased pulsatile release of GH stimulated by this blend has the potential to enhance IGF-1 activity, positively impacting bone density and body composition. This may manifest in increased lean mass and a reduction in body fat percentage and BMI. The synergistic effects on GH release suggest potential benefits such as fat loss, increased body mass, and improved cholesterol levels.

Through complementary mechanisms, sermorelin and GHRP-6 work together to naturally amplify GH secretion for benefits on overall body composition, body weight, and metabolic factors.

Frequently Asked Questions

What is the Sermorelin and GHRP-6 blend?

Sermorelin/GHRP-6 is a blended injectable peptide compound comprised of the two components sermorelin and GHRP-6, both of which have the potential to stimulate increased natural growth hormone secretion.

What are the effects of this blend?

By restoring youthful pulsatile GH release, the blend may have the potential to increase muscle mass, exercise capacity, energy levels, bone density, and cognition while improving body composition through enhanced metabolism.

Is this blend legally available?

The peptides are individually FDA-approved for research use only. Specific blends have not been evaluated clinically so are not legally available without a prescription for clinical use.

Why Buy Sermorelin + GHRP 6 Blend from BehemothLabz?

BehemothLabz is the best place to purchase Sermorelin and GHRP-6.

We have been around since 2014, supplying the highest-quality research compounds money can buy. All of our products come with a 100% satisfaction guarantee, free and fast shipping, and a money-back guarantee on Sermorelin and GHRP-6.

Summary

The combination of sermorelin, a growth hormone-releasing peptide, and GHRP-6, a growth hormone secretagogue, in one blend, has the potential to significantly stimulate increased pulsatile growth hormone secretion from the pituitary gland, surpassing levels produced by either compound alone. This blend aims to restore youthful, naturally produced human growth hormone levels, potentially leading to increased lean body mass, muscle growth, bone density, and exercise capacity.

The synergistic surge in GH from this blend also has the potential to enhance IGF-1 activity, promoting anabolic effects and potentially improving body composition by reducing body fat and BMI. Acting as potent stimulators of GH release, sermorelin, and GHRP-6 work in tandem to potentially elevate GH peaks, resulting in reduced fat mass and weight gain compared to sermorelin or GHRP-2 treatment alone.

Administered daily under qualified medical supervision, this blend is designed to confer anti-inflammatory benefits and metabolically support healthy body composition without adverse effects. While still investigational, the literature suggests promising and beneficial effects of blended sermorelin and GHRP-6 to potentially increase natural GH levels, offering participants the opportunity to achieve similar benefits as synthetic GH therapy.

Strength	10mg